Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

NCT04168502 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

414

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Gemtuzumab Ozogamicin

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto